DCF Valuation

VivoSim Labs, Inc. (VIVS) DCF Valuation — Is VIVS undervalued?

The estimated DCF fair value of one VivoSim Labs, Inc. (VIVS) share is $0.88. Compared to the current market price of $0.36, the stock is undervalued by 141.0%.

DCF fair value

$0.88

Market price

$0.36

Upside / downside

+141.0%

Run the full interactive DCF model →

VivoSim Labs, Inc. (VIVS) DCF valuation FAQ

What is the DCF fair value of VivoSim Labs, Inc. (VIVS)?

The discounted-cash-flow model estimates the intrinsic fair value of one VivoSim Labs, Inc. (VIVS) share at $0.88, based on a 10-year projection of its cash flows converging to Damodaran industry averages.

Is VivoSim Labs, Inc. (VIVS) overvalued or undervalued?

Against the current market price of $0.36, the DCF fair value of $0.88 implies VIVS is undervalued by 141.0%.

How is the VIVS DCF value calculated?

It is a 10-year discounted-cash-flow estimate built from VivoSim Labs, Inc.'s reported fundamentals, with terminal assumptions anchored to Damodaran NYU industry datasets. The market price refreshes daily; the DCF fair value updates when VivoSim Labs, Inc. files a new quarterly or annual report.

How this VIVS valuation is built

The model projects ten years of VivoSim Labs, Inc.'s free cash flow to the firm and discounts each year at its own cost of capital. Rather than assuming today's growth and margins persist forever, a moat-scoring step — weighing VivoSim Labs, Inc.'s ROIC-versus-WACC spread, gross-margin trend, and reinvestment efficiency — decides how many years the business holds its edge before its economics mean-revert toward the Damodaran NYU benchmarks for its industry.

WACC is rebuilt each year from an unlevered-then-relevered beta and the company's evolving capital structure; terminal value uses the Gordon growth model with a reinvestment rate tied to the return earned on new capital (goodwill stripped out to reflect operating efficiency). Every assumption — growth, margins, tax, leverage, convergence timing — is editable, and running the full interactive model adds a 10,000-draw Monte Carlo simulation and WACC-versus-terminal-growth sensitivity heatmaps.

The market price refreshes daily; the DCF fair value updates when VivoSim Labs, Inc. files a new quarterly or annual report. For educational/informational purposes only — not investment advice. Last updated 2026-08-06.